Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,527
52-wk High
$3.34
52-wk Low
$1.11

Select another date:

Wed, Nov 22 2017

BRIEF-Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​

* Acasti Pharma Inc - ‍clarifies term of proposed strategic partnership with China pharmaceutical company​

BRIEF-Acasti Pharma ‍enters into non-binding agreement with China-based pharma

* Acasti Pharma Inc - ‍entered into a non-binding term sheet with a China-based pharmaceutical company​

BRIEF-Acasti Pharma says is offering 11.7 mln common shares‍​

* Says it is offering 11.7 million common shares‍​ - SEC Filing Source text: (http://bit.ly/2mBXlkS) Further company coverage:

BRIEF-Acasti Pharma reports Q2 loss per share C‍$0.31​

* Acasti Pharma reports second quarter FY 2018 financial results

BRIEF-Acasti Pharma files for offering of up to $17.25 mln of common stock‍​

* Acasti Pharma Inc files for offering of up to $17.25 million of common stock‍​ - sec filing‍​ Source text : http://bit.ly/2yN6Pf7 Further company coverage:

BRIEF-Acasti Pharma reports Q1 loss per share c$0.19

* Acasti Pharma reports first quarter fy 2018 financial results

BRIEF-Acasti Pharma issues common shares in payment of outstanding interest under debentures

* Acasti Pharma announces issuance of common shares in payment of outstanding interest under debentures Source text for Eikon: Further company coverage:

Select another date: